Dover reports Q1 adjusted EPS $1.95, consensus $1.87

Reports Q1 revenue $2.09B, consensus $2.03B. Dover’s president and CEO, Richard Tobin, said, “Dover’s first quarter results were in line with our expectations. We are particularly pleased with the success of our organic growth platforms, as well as the order trends in the quarter, which validate the aggressive working capital posture we adopted in 2023. Order momentum in the quarter was strong and broad-based, particularly in our shorter-cycle end markets, building off the prior year exit rate and bolstering confidence in our full year outlook. Strong growth in several key markets and improving performance in biopharma components set us up for favorable sequential margin mix over the balance of the year.